Treatment of acute lymphoblastic leukemia

Annu Rev Med. 1972:23:77-92. doi: 10.1146/annurev.me.23.020172.000453.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adrenocorticotropic Hormone / therapeutic use
  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / pharmacology
  • Asparaginase / therapeutic use
  • Central Nervous System Diseases / prevention & control
  • Child
  • Cyclophosphamide / therapeutic use
  • Cytarabine / therapeutic use
  • Cytopathogenic Effect, Viral
  • Daunorubicin / therapeutic use
  • Humans
  • Kinetics
  • Leukemia, Experimental / drug therapy
  • Leukemia, Lymphoid / drug therapy*
  • Leukemia, Lymphoid / microbiology
  • Leukemia, Lymphoid / mortality
  • Meninges
  • Mercaptopurine / therapeutic use
  • Methotrexate / therapeutic use
  • Mice
  • Oncogenic Viruses / pathogenicity
  • Patient Care Team
  • RNA Viruses / enzymology
  • RNA-Directed DNA Polymerase / metabolism
  • Remission, Spontaneous
  • Reverse Transcriptase Inhibitors
  • Time Factors
  • Vincristine / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Antineoplastic Agents
  • Reverse Transcriptase Inhibitors
  • Cytarabine
  • Vincristine
  • Cyclophosphamide
  • Adrenocorticotropic Hormone
  • Mercaptopurine
  • RNA-Directed DNA Polymerase
  • Asparaginase
  • Methotrexate
  • Daunorubicin